These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34459435)

  • 1. Tardive Myoclonus Responsive to Clozapine Misdiagnosed as Restless Leg Syndrome: A Case Report.
    Selçuk M
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):692-694. PubMed ID: 34459435
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of low-Dose Aripiprazole to Treat Clozapine-Associated Tardive Dystonia in a Patient with Schizophrenia].
    Huh L; Lee BJ
    Turk Psikiyatri Derg; 2017; 28(3):208-211. PubMed ID: 28936820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
    Beasley CM; Dellva MA; Tamura RN; Morgenstern H; Glazer WM; Ferguson K; Tollefson GD
    Br J Psychiatry; 1999 Jan; 174():23-30. PubMed ID: 10211147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expected incidence of tardive dyskinesia associated with atypical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():21-6. PubMed ID: 10739327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis.
    Jain R; Correll CU
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29570969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
    Andia I; Zumarraga M; Zabalo MJ; Bulbena A; Davila R
    Biol Psychiatry; 1998 Jan; 43(1):20-3. PubMed ID: 9442340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia.
    McEvoy JP; Kremens DE
    J Clin Psychiatry; 2020 Jan; 81(1):. PubMed ID: 31995674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors.
    Duggal HS; Mendhekar DN
    Am J Psychiatry; 2006 Aug; 163(8):1449-50. PubMed ID: 16877664
    [No Abstract]   [Full Text] [Related]  

  • 13. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA; Factor SA; Marder SR; Knesevich MA; Ramirez PM; Jimenez R; Burke J; Liang GS; O'Brien CF
    Am J Psychiatry; 2017 May; 174(5):476-484. PubMed ID: 28320223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.
    Oosthuizen PP; Emsley RA; Maritz JS; Turner JA; Keyter N
    J Clin Psychiatry; 2003 Sep; 64(9):1075-80. PubMed ID: 14628983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins.
    She S; Kuang Q; Zheng Y
    Schizophr Res; 2018 Jul; 197():564-565. PubMed ID: 29128325
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of clozapine-associated restless leg syndrome with pramipexole.
    John AP; Adriana S; La'Brooy JA; Piepiorka-Sokolowska D
    J Clin Psychopharmacol; 2014 Dec; 34(6):764-6. PubMed ID: 25300012
    [No Abstract]   [Full Text] [Related]  

  • 17. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs.
    Manning JS
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride Induced Oropharyngeal Dyskinesia in a patient with Schizophrenia: A case report and review of literature.
    Gowda GS; Sastry Nagavarapu LS; Reddy Mukku SS; Farooq Ali S
    Asian J Psychiatr; 2019 Mar; 41():78-81. PubMed ID: 29146045
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.